Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Intravenous Immunoglobulin market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Intravenous Immunoglobulin market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Intravenous Immunoglobulin market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Intravenous Immunoglobulin products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Intravenous Immunoglobulin products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Intravenous Immunoglobulin market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Intravenous Immunoglobulin development has been the leading industry trend of Intravenous Immunoglobulin market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Intravenous Immunoglobulin Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Neurology Intravenous Immunoglobulins, Hematology Intravenous Immunoglobulins, Immunology Intravenous Immunoglobulins, Other |
| By Application Outlook |
Primary Immunodeficiency, Idiopathic Thrombocytopenic Purpura, Chronic Inflammatory Demyelinating Polyneuropathy, Kawasaki Disease, Guillain-Barre Syndrome |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
CSL Behring, Grifols, Octapharma, Shire, ADMA Biologics, Bayer, Bharat Serum and Vaccines, Biotest, China Biologic Products, Hualan Biological Engineering, Kedrion Biopharma, LFB Group, Sanquin |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- CSL Behring
- Grifols
- Octapharma
- Shire
- ADMA Biologics
- Bayer
- Bharat Serum and Vaccines
- Biotest
- China Biologic Products
- Hualan Biological Engineering
- Kedrion Biopharma
- LFB Group
- Sanquin
INTRAVENOUS IMMUNOGLOBULIN Market, By Type
- Neurology Intravenous Immunoglobulins
- Hematology Intravenous Immunoglobulins
- Immunology Intravenous Immunoglobulins
- Other
INTRAVENOUS IMMUNOGLOBULINMarket, By Application
- Primary Immunodeficiency
- Idiopathic Thrombocytopenic Purpura
- Chronic Inflammatory Demyelinating Polyneuropathy
- Kawasaki Disease
- Guillain-Barre Syndrome
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Intravenous Immunoglobulins Market Overview
1.1 Intravenous Immunoglobulins Product Overview
1.2 Intravenous Immunoglobulins Market Segment by Type
1.2.1 Neurology Intravenous Immunoglobulins
1.2.2 Hematology Intravenous Immunoglobulins
1.2.3 Immunology Intravenous Immunoglobulins
1.3 Global Intravenous Immunoglobulins Market Size by Type
1.3.1 Global Intravenous Immunoglobulins Sales and Growth by Type
1.3.2 Global Intravenous Immunoglobulins Sales and Market Share by Type (2014-2019)
1.3.3 Global Intravenous Immunoglobulins Revenue and Market Share by Type (2014-2019)
1.3.4 Global Intravenous Immunoglobulins Price by Type (2014-2019)
2 Global Intravenous Immunoglobulins Market Competition by Company
2.1 Global Intravenous Immunoglobulins Sales and Market Share by Company (2014-2019)
2.2 Global Intravenous Immunoglobulins Revenue and Share by Company (2014-2019)
2.3 Global Intravenous Immunoglobulins Price by Company (2014-2019)
2.4 Global Top Players Intravenous Immunoglobulins Manufacturing Base Distribution, Sales Area, Product Types
2.5 Intravenous Immunoglobulins Market Competitive Situation and Trends
2.5.1 Intravenous Immunoglobulins Market Concentration Rate
2.5.2 Global Intravenous Immunoglobulins Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Intravenous Immunoglobulins Company Profiles and Sales Data
3.1 CSL Behring
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Intravenous Immunoglobulins Product Category, Application and Specification
3.1.3 CSL Behring Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Grifols
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Intravenous Immunoglobulins Product Category, Application and Specification
3.2.3 Grifols Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Octapharma
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Intravenous Immunoglobulins Product Category, Application and Specification
3.3.3 Octapharma Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Shire
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Intravenous Immunoglobulins Product Category, Application and Specification
3.4.3 Shire Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 ADMA Biologics
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Intravenous Immunoglobulins Product Category, Application and Specification
3.5.3 ADMA Biologics Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Bayer
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Intravenous Immunoglobulins Product Category, Application and Specification
3.6.3 Bayer Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Bharat Serum and Vaccines
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Intravenous Immunoglobulins Product Category, Application and Specification
3.7.3 Bharat Serum and Vaccines Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Biotest
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Intravenous Immunoglobulins Product Category, Application and Specification
3.8.3 Biotest Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 China Biologic Products
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Intravenous Immunoglobulins Product Category, Application and Specification
3.9.3 China Biologic Products Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Hualan Biological Engineering
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Intravenous Immunoglobulins Product Category, Application and Specification
3.10.3 Hualan Biological Engineering Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
3.11 Kedrion Biopharma
3.12 LFB Group
3.13 Sanquin
4 Intravenous Immunoglobulins Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Intravenous Immunoglobulins Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Intravenous Immunoglobulins Sales and Revenue by Regions
4.2.1 Global Intravenous Immunoglobulins Sales and Market Share by Regions (2014-2019)
4.2.2 Global Intravenous Immunoglobulins Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Intravenous Immunoglobulins Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Intravenous Immunoglobulins Application/End Users
5.1 Intravenous Immunoglobulins Segment by Application
5.1.1 Primary Immunodeficiency
5.1.2 Idiopathic Thrombocytopenic Purpura
5.1.3 Chronic Inflammatory Demyelinating Polyneuropathy
5.1.4 Kawasaki Disease
5.1.5 Guillain-Barre Syndrome
5.2 Global Intravenous Immunoglobulins Product Segment by Application
5.2.1 Global Intravenous Immunoglobulins Sales by Application
5.2.2 Global Intravenous Immunoglobulins Sales and Market Share by Application (2014-2019)
6 Global Intravenous Immunoglobulins Market Forecast
6.1 Global Intravenous Immunoglobulins Sales, Revenue Forecast (2019-2025)
6.1.1 Global Intravenous Immunoglobulins Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Intravenous Immunoglobulins Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Intravenous Immunoglobulins Forecast by Regions
6.2.1 North America Intravenous Immunoglobulins Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Intravenous Immunoglobulins Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Intravenous Immunoglobulins Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Intravenous Immunoglobulins Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Intravenous Immunoglobulins Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Intravenous Immunoglobulins Forecast by Type
6.3.1 Global Intravenous Immunoglobulins Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Neurology Intravenous Immunoglobulins Gowth Forecast
6.3.3 Hematology Intravenous Immunoglobulins Gowth Forecast
6.4 Intravenous Immunoglobulins Forecast by Application
6.4.1 Global Intravenous Immunoglobulins Sales Forecast by Application (2019-2025)
6.4.2 Global Intravenous Immunoglobulins Forecast in Primary Immunodeficiency
6.4.3 Global Intravenous Immunoglobulins Forecast in Idiopathic Thrombocytopenic Purpura
7 Intravenous Immunoglobulins Upstream Raw Materials
7.1 Intravenous Immunoglobulins Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Intravenous Immunoglobulins Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
